SCHEMBL3476274

SCHEMBL3476274

COCCOCCOC#Cc1cc(C)cc(C)c1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3477705 0.71 FFAR1 (0.34) FFAR1
SCHEMBL13021583 0.68 MEN1 (0.45)
M-Xylene SCHEMBL4808897 0.67 ACHE (0.55)
SCHEMBL8300223 0.66 TACR1 (0.43)
SCHEMBL3691802 0.65 FFAR1 (0.45) FFAR1
SCHEMBL10348443 0.63 MAPT (0.51)
SCHEMBL10348383 0.63 MAPT (0.51)
SCHEMBL10348410 0.63 MAPT (0.51)
SCHEMBL10348382 0.63 MAPT (0.51)
SCHEMBL10348444 0.63 MAPT (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420235-B2 Emissive diaryl acetylenes NITTO DENKO CORPORATION (JP) 2013-04-16 US disclosed
US-8323805-B2 Emissive aryl-heteroaryl acetylenes NITTO DENKO CORPORATION (JP) 2012-12-04 US disclosed
US-20100308310-A1 EMISSIVE ARYL-HETEROARYL ACETYLENES Nitto Denko Corporaton (JP) 2010-12-09 US disclosed
WO-2010141758-A1 EMISSIVE ARYL-HETEROARYL ACETYLENES NITTO DENKO CORPORATION (JP) 2010-12-09 WO disclosed
US-20100308716-A1 EMISSIVE DIARYL ACETYLENES NITTO DENKO CORPORATION (JP) 2010-12-09 US disclosed
WO-2010141754-A1 EMISSIVE DIARYL ACETYLENES NITTO DENKO CORPORATION (JP) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308310-A1 EMISSIVE ARYL-HETEROARYL ACETYLENES NAT1, AADAC, CORO1C FFAR1 2545/4885
US-20100308716-A1 EMISSIVE DIARYL ACETYLENES B3GNT2, GSTO1, NAT1 FFAR1 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.